Abstract
Objective:
In the management of twin reversed arterial perfusion (TRAP) sequence, we wished to (i) determine if intervention is better than a conservative approach and (ii) assess if any of the apparent adverse prognostic indicators could guide intervention.
Methods:
A systematic review was conducted between 1994 and 2014. Data extracted were inspected for heterogeneity. Overall rates and confidence intervals (CIs) for each prognostic factor were calculated. Where there were comparative data, the odds ratio (OR) was calculated.
Results:
Twenty-six studies were included in the review. When all cases were considered, intervention either by cord occlusion or by ablation conferred a better survival rate compared with conservative management (OR=2.22, 95% CI 1.23–4.01, heterogeneity I2=37%, P=0.008). This difference was greater in the presence of one or more poor prognostic features (OR=8.58, 95% CI 1.47–49.96, heterogeneity I2=0%, P=0.02). Survival was better using ablative techniques compared to cord occlusion (OR=9.84, 95% CI 1.56–62.00, heterogeneity I2=0%, P=0.01).
Conclusion:
Intervention either by cord occlusion or by ablation confers a better survival rate compared to conservative management. This appears more compelling if there are one or more poor prognostic features. Ablative techniques are superior to cord occlusion. There were insufficient data to determine which poor prognostic features should guide management.
References
[1] Byrne FA, Lee H, Kipps AK, Brook MM, Moon-Grady AJ. Echocardiographic risk stratification of fetuses with sacrococcygeal teratoma and twin-reversed arterial perfusion. Fetal Diagn Ther. 2011;30:280–8.10.1159/000330762Search in Google Scholar PubMed
[2] Berg C, Holst D, Mallmann MR, Gottschalk I, Gembruch U, Geipel A. Early vs late intervention in twin reversed arterial perfusion sequence. Ultrasound Obstet Gynecol. 2014;43: 60–4.10.1002/uog.12578Search in Google Scholar PubMed
[3] Jelin E, Hirose S, Rand L, Curran P, Feldstein V, Guevara-Gallardo S, et al. Perinatal outcome of conservative management versus fetal intervention for twin reversed arterial perfusion sequence with a small acardiac twin. Fetal Diagn Ther. 2010;27:138–41.10.1159/000295176Search in Google Scholar PubMed
[4] Pagani G, D’Antonio F, Khalil A, Papageorghiou A, Bhide A, Thilaganathan B. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis. Ultrasound Obstet Gynecol. 2013;42:6–14.10.1002/uog.12495Search in Google Scholar PubMed
[5] Chaveeva P, Poon LC, Sotiriadis A, Kosinski P, Nicolaides KH. Optimal method and timing of intrauterine intervention in twin reversed arterial perfusion sequence: case study and meta-analysis. Fetal Diagn Ther. 2014;35:267–79.10.1159/000358593Search in Google Scholar PubMed
[6] Peeters SH, Devlieger R, Middeldorp JM, DeKoninck P, Deprest J, Lopriore E, et al. Fetal surgery in complicated monoamniotic pregnancies: case series and systematic review of the literature. Prenatal Diag. 2014;34:586–91.10.1002/pd.4353Search in Google Scholar PubMed
[7] Lewi L, Valencia C, Gonzalez E, Deprest J, Nicolaides KH. The outcome of twin reversed arterial perfusion sequence diagnosed in the first trimester. Am J Obstet Gynecol. 2010;203:213 e211–4.10.1016/j.ajog.2010.04.018Search in Google Scholar PubMed
[8] von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4:e296.10.1097/EDE.0b013e3181577654Search in Google Scholar PubMed
[9] Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. J Am Med Assoc. 2000;283:2008–12.10.1001/jama.283.15.2008Search in Google Scholar PubMed
[10] Khan K, Riet G, Glanville J. Undertaking systematic reviews of research on effectiveness. CRD’s Guidance for carrying out or commissioning reviews. 2nd ed. York: NHS Centre for Reviews and Dissemination, University of York; 2000.Search in Google Scholar
[11] Henderson LK, Craig JC, Willis NS, Tovey D, Webster AC. How to write a Cochrane systematic review. Nephrology (Carlton). 2010;15:617–24.10.1111/j.1440-1797.2010.01380.xSearch in Google Scholar PubMed
[12] NHS Centre for Reviews and Dissemination. CRD’s guidance for undertaking reviews in health care. York: NHS Centre for Reviews and Dissemination; 2009.Search in Google Scholar
[13] Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006–12.10.1016/j.jclinepi.2009.06.005Search in Google Scholar
[14] Rennie D. Improving reports of studies of diagnostic tests: the STARD initiative. J Am Med Assoc. 2003;289:89–90.10.1001/jama.289.1.89Search in Google Scholar
[15] Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. Br Med J. 1994;309:1351–5.10.1136/bmj.309.6965.1351Search in Google Scholar
[16] DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.10.1016/0197-2456(86)90046-2Search in Google Scholar
[17] SPSS for Windows [computer program]. Version Rel. 11.0.1. Chicago, IL: SPSS; 2001.10.1007/978-3-322-93157-3_1Search in Google Scholar
[18] Sutton A, Abrams K, Jones D, Sheldon T, Song F. Methods for meta-analysis in medical research. Chichester: Wiley; 2000.Search in Google Scholar
[19] Deeks J, Altman D, Bradburn M. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman D, editors. Systematic reviews in health care:meta-analysis in context. London: Br Med J Books; 2001.Search in Google Scholar
[20] Review Manager(RevMan) [computer program]. Version 5. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2008.Search in Google Scholar
[21] Weisz B, Peltz R, Chayen B, Oren M, Zalel Y, Achiron R, et al. Tailored management of twin reversed arterial perfusion (TRAP) sequence. Ultrasound Obstet Gynecol. 2004;23:451–5.10.1002/uog.1040Search in Google Scholar PubMed
[22] Bebbington MW, Danzer E, Moldenhauer J, Khalek N, Johnson MP. Radiofrequency ablation vs bipolar umbilical cord coagulation in the management of complicated monochorionic pregnancies. Ultrasound Obstet Gynecol. 2012;40:319–24.10.1002/uog.11122Search in Google Scholar PubMed
[23] Beck V, Lewi P, Gucciardo L, Devlieger R. Preterm prelabor rupture of membranes and fetal survival after minimally invasive fetal surgery: a systematic review of the literature. Fetal Diagn Ther. 2012;31:1–9.10.1159/000331165Search in Google Scholar PubMed
[24] Brassard M, Fouron JC, Leduc L, Grignon A, Proulx F. Prognostic markers in twin pregnancies with an acardiac fetus. Obstet Gynecol. 1999;94:409–14.Search in Google Scholar
[25] Cabassa P, Fichera A, Prefumo F, Taddei F, Gandolfi S, Maroldi R, et al. The use of radiofrequency in the treatment of twin reversed arterial perfusion sequence: a case series and review of the literature. Eur J Obstet Gynecol Reprod Biol. 2013;166:127–32.10.1016/j.ejogrb.2012.10.009Search in Google Scholar PubMed
[26] Corbacioglu A, Gul A, Bakirci IT, Gedikbasi A, Yildirim G. Treatment of twin reversed arterial perfusion sequence with alcohol ablation or bipolar cord coagulation. Int J Gynaecol Obstet. 2012;117:257–9.10.1016/j.ijgo.2011.12.022Search in Google Scholar PubMed
[27] Dashe JS, Fernandez CO, Twickler DM. Utility of Doppler velocimetry in predicting outcome in twin reversed-arterial perfusion sequence. Am J Obstet Gynecol. 2001;185:135–9.10.1067/mob.2001.113906Search in Google Scholar PubMed
[28] Delabaere A, Favre N, Velemir L, Bentaoui S, Coste K, Laurichesse-Demas H, et al. [Pediatric outcome after selective feticide for 30 complicated monochorionic twin pregnancies]. Gynecol Obstet Fertil. 2013;41:85–9.10.1016/j.gyobfe.2012.12.007Search in Google Scholar PubMed
[29] Dias T, Contro E, Thilaganathan B, Khan H, Zanardini C, Mahsud-Dornan S, et al. Pregnancy outcome of monochorionic twins: does amnionicity matter? Twin Res Hum Genet. 2011;14:586–592.10.1375/twin.14.6.586Search in Google Scholar PubMed
[30] Gul A, Gungorduk K, Yildirim G, Gedikbasi A, Yildirim D, Ceylan Y. Fetal therapy in twin reversed arterial perfusion sequence pregnancies with alcohol ablation or bipolar cord coagulation. Arch Gynecol Obstet. 2008;278:541–5.10.1007/s00404-008-0640-5Search in Google Scholar PubMed
[31] Hartge DR, Weichert J. Prenatal diagnosis and outcome of multiple pregnancies with reversed arterial perfusion (TRAP-sequence). Arch Gynecol Obstet. 2012;286:81–8.10.1007/s00404-012-2283-9Search in Google Scholar PubMed
[32] Hecher K, Lewi L, Gratacos E, Huber A, Ville Y, Deprest J. Twin reversed arterial perfusion: fetoscopic laser coagulation of placental anastomoses or the umbilical cord. Ultrasound Obstet Gynecol. 2006;28:688–91.10.1002/uog.3816Search in Google Scholar PubMed
[33] Lanna MM, Rustico MA, Dell’Avanzo M, Schena V, Faiola S, Consonni D, et al. Bipolar cord coagulation for selective feticide in complicated monochorionic twin pregnancies: 118 consecutive cases at a single center. Ultrasound Obstet Gynecol. 2012;39:407–13.10.1002/uog.11073Search in Google Scholar PubMed
[34] Leduc L, Takser L, Rinfret D. Persistance of adverse obstetric and neonatal outcomes in monochorionic twins after exclusion of disorders unique to monochorionic placentation. Am J Obstet Gynecol. 2005;193:1670–5.10.1016/j.ajog.2005.04.007Search in Google Scholar PubMed
[35] Lee H, Wagner AJ, Sy E, Ball R, Feldstein VA, Goldstein RB, et al. Efficacy of radiofrequency ablation for twin-reversed arterial perfusion sequence. Am J Obstet Gynecol. 2007;196:459 e451–4.10.1016/j.ajog.2006.11.039Search in Google Scholar PubMed
[36] Livingston JC, Lim FY, Polzin W, Mason J, Crombleholme TM. Intrafetal radiofrequency ablation for twin reversed arterial perfusion (TRAP): a single-center experience. Am J Obstet Gynecol. 2007;197:399 e391–3.10.1016/j.ajog.2007.07.051Search in Google Scholar PubMed
[37] O’Donoghue K, Barigye O, Pasquini L, Chappell L, Wimalasundera RC, Fisk NM. Interstitial laser therapy for fetal reduction in monochorionic multiple pregnancy: loss rate and association with aplasia cutis congenita. Prenatal Diag. 2008;28:535–43.10.1002/pd.2025Search in Google Scholar PubMed
[38] Quintero RA, Chmait RH, Murakoshi T, Pankrac Z, Swiatkowska M, Bornick PW, et al. Surgical management of twin reversed arterial perfusion sequence. Am J Obstet Gynecol. 2006;194:982–91.10.1016/j.ajog.2005.10.195Search in Google Scholar PubMed
[39] Rossi AC, D’Addario V. Umbilical cord occlusion for selective feticide in complicated monochorionic twins: a systematic review of literature. Am J Obstet Gynecol. 2009;200:123–9.10.1016/j.ajog.2008.08.039Search in Google Scholar PubMed
[40] Scheier M, Molina FS. Outcome of twin reversed arterial perfusion sequence following treatment with interstitial laser: a retrospective study. Fetal Diagn Ther. 2012;31:35–41.10.1159/000334156Search in Google Scholar PubMed
[41] Spadola AC, Simpson LL. Selective termination procedures in monochorionic pregnancies. Semin Perinatol. 2005;29:330–7.10.1053/j.semperi.2005.09.001Search in Google Scholar PubMed
[42] Tan TY, Sepulveda W. Acardiac twin: a systematic review of minimally invasive treatment modalities. Ultrasound Obstet Gynecol. 2003;22:409–19.10.1002/uog.224Search in Google Scholar PubMed
[43] Tsao K, Feldstein VA, Albanese CT, Sandberg PL, Lee H, Harrison MR, et al. Selective reduction of acardiac twin by radiofrequency ablation. Am J Obstet Gynecol. 2002;187:635–40.10.1067/mob.2002.125242Search in Google Scholar PubMed
[44] Vandecruys H, Avgidou K, Surerus E, Flack N, Nicolaides KH. Dilemmas in the management of twins discordant for anencephaly diagnosed at 11 + 0–13 + 6 weeks of gestation. Ultrasound Obstet Gynecol. 2006;28:653–8.10.1002/uog.2836Search in Google Scholar PubMed
[45] Ville Y, Hyett JA, Vandenbussche FP, Nicolaides KH. Endoscopic laser coagulation of umbilical cord vessels in twin reversed arterial perfusion sequence. Ultrasound Obstet Gynecol. 1994;4:396–8.10.1046/j.1469-0705.1994.04050396.xSearch in Google Scholar PubMed
[46] Has R, Kalelioglu I, Corbacioglu Esmer A, Ermis H, Dural O, Dogan Y, et al. Bipolar cord coagulation in the management of complicated monochorionic twin pregnancies. Fetal Diagn Ther. 2014;36:190–5.10.1159/000360853Search in Google Scholar PubMed
[47] Holmes A, Jauniaux E, Rodeck C. Monopolar thermocoagulation in acardiac twinning. Br J Obst Gyn. 2001;108:1000–2.10.1111/j.1471-0528.2001.00234.xSearch in Google Scholar PubMed
[48] Paramasivam G, Wimalasundera R, Wiechec M, Zhang E, Saeed F, Kumar S. Radiofrequency ablation for selective reduction in complex monochorionic pregnancies. Br J Obst Gyn. 2010;117:1294–8.10.1111/j.1471-0528.2010.02624.xSearch in Google Scholar PubMed
[49] Roman A, Papanna R, Johnson A, Zhang E, Saeed F, Kumar S. Selective reduction in complicated monochorionic pregnancies: radiofrequency ablation vs. bipolar cord coagulation. Ultrasound Obstet Gynecol. 2010;36:37–41.10.1002/uog.7567Search in Google Scholar PubMed
[50] Sepulveda W, Corral E, Aiello H, Otaño L, Paredes R, Escobar MF, et al. Intrafetal alcohol chemosclerosis of acardiac twins: a multicenter experience. Fetal Diagn Ther. 2004;19:448–52.10.1159/000078998Search in Google Scholar PubMed
[51] Lee H, Bebbington M, Crombleholme TM. The North American fetal therapy network registry data on outcomes of radiofrequency ablation for twin-reversed arterial perfusion sequence. Fetal Diagn Ther. 2013;33:224–9.10.1159/000343223Search in Google Scholar PubMed
The authors stated that there are no conflicts of interest regarding the publication of this article.
©2016 Walter de Gruyter GmbH, Berlin/Boston